» Articles » PMID: 21736547

Recent Progress Toward Hydrogen Medicine: Potential of Molecular Hydrogen for Preventive and Therapeutic Applications

Overview
Journal Curr Pharm Des
Date 2011 Jul 9
PMID 21736547
Citations 113
Authors
Affiliations
Soon will be listed here.
Abstract

Persistent oxidative stress is one of the major causes of most lifestyle-related diseases, cancer and the aging process. Acute oxidative stress directly causes serious damage to tissues. Despite the clinical importance of oxidative damage, antioxidants have been of limited therapeutic success. We have proposed that molecular hydrogen (H(2)) has potential as a "novel" antioxidant in preventive and therapeutic applications [Ohsawa et al., Nat Med. 2007: 13; 688-94]. H(2) has a number of advantages as a potential antioxidant: H(2) rapidly diffuses into tissues and cells, and it is mild enough neither to disturb metabolic redox reactions nor to affect reactive oxygen species (ROS) that function in cell signaling, thereby, there should be little adverse effects of consuming H(2). There are several methods to ingest or consume H(2), including inhaling hydrogen gas, drinking H(2)-dissolved water (hydrogen water), taking a hydrogen bath, injecting H(2)- dissolved saline (hydrogen saline), dropping hydrogen saline onto the eye, and increasing the production of intestinal H(2) by bacteria. Since the publication of the first H(2) paper in Nature Medicine in 2007, the biological effects of H(2) have been confirmed by the publication of more than 38 diseases, physiological states and clinical tests in leading biological/medical journals, and several groups have started clinical examinations. Moreover, H(2) shows not only effects against oxidative stress, but also various anti-inflammatory and antiallergic effects. H(2) regulates various gene expressions and protein-phosphorylations, though the molecular mechanisms underlying the marked effects of very small amounts of H(2) remain elusive.

Citing Articles

Hydrogen-oxygen mixture inhalation as an adjunctive treatment to home-based exercise in older patients with knee osteoarthritis: an open-label, blinded-endpoint, randomized controlled trial.

Wang C, Yan M, Li Y, Han L, Wang H, Jia S Front Pharmacol. 2025; 16:1505922.

PMID: 39950118 PMC: 11821916. DOI: 10.3389/fphar.2025.1505922.


A comprehensive review of molecular hydrogen as a novel nutrition therapy in relieving oxidative stress and diseases: Mechanisms and perspectives.

Yildiz F, LeBaron T, Alwazeer D Biochem Biophys Rep. 2025; 41:101933.

PMID: 39911528 PMC: 11795818. DOI: 10.1016/j.bbrep.2025.101933.


Pharmacokinetics of Hydrogen During Hydrogen-Saturated Saline Infusion in Pigs.

Shibuya M, Fujinaka M, Yonezawa M, Nishimura N, Uchinoumi H, Sunahara H Biomedicines. 2025; 13(1.

PMID: 39857817 PMC: 11762721. DOI: 10.3390/biomedicines13010234.


Efficacy of a hydrogen-oxygen generator in treating cigarette smoke-induced chronic obstructive pulmonary disease in rats.

Huang W, Cheng T, Huang L, Hou Y Curr Res Toxicol. 2025; 8():100214.

PMID: 39839142 PMC: 11745982. DOI: 10.1016/j.crtox.2024.100214.


New possibilities of the prevention and treatment of cardiovascular pathologies. the potential of molecular hydrogen in the reduction of oxidative stress and its consequences.

Slezak J, Ravingerova T, Kura B Physiol Res. 2025; 73(S3):S671-S684.

PMID: 39808170 PMC: 11827053. DOI: 10.33549/physiolres.935491.


References
1.
Cai J, Kang Z, Liu K, Liu W, Li R, Zhang J . Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model. Brain Res. 2008; 1256:129-37. DOI: 10.1016/j.brainres.2008.11.048. View

2.
Murphy M . Selective targeting of bioactive compounds to mitochondria. Trends Biotechnol. 1997; 15(8):326-30. DOI: 10.1016/S0167-7799(97)01068-8. View

3.
Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K . Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007; 13(6):688-94. DOI: 10.1038/nm1577. View

4.
Schriner S, Linford N, Martin G, Treuting P, Ogburn C, Emond M . Extension of murine life span by overexpression of catalase targeted to mitochondria. Science. 2005; 308(5730):1909-11. DOI: 10.1126/science.1106653. View

5.
Chandel N, Maltepe E, GOLDWASSER E, Mathieu C, Simon M, Schumacker P . Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A. 1998; 95(20):11715-20. PMC: 21706. DOI: 10.1073/pnas.95.20.11715. View